Service is in preparation Official β release coming soon. Some features are still being adjusted.

Investical Earnings & investing calendar Earnings & investing calendar
/
CCytosorbents Corporation logo
CTSONASDAQ

Cytosorbents Corporation

Cytosorbents Corporation
Loading price data…
Loading price data…
Chart type
Interval
Moving averages
Up/down colors

Share screenshot

Recent & upcoming events

Aug 13
Shareholder meeting Time TBD
Annual meeting (per DEF 14A)
Add to Google Calendar
Aug 12
Filing Time TBD
Quarterly report (10-Q) filing due (est.)
Add to Google Calendar
Aug 6
Earnings 16:30
Earnings announcement (第2四半期)
Add to Google Calendar
Earnings 16:30
Earnings call (第2四半期)
Add to Google Calendar
May 13
Earnings Time TBD
Q1 earnings
Add to Google Calendar
Mar 25
Earnings Time TBD
Full-year earnings
Add to Google Calendar
2025
Nov 13
Earnings Time TBD
Q3 earnings
Add to Google Calendar
Mar 31
Earnings Time TBD
Full-year earnings
Add to Google Calendar
Jan 13
Earnings Time TBD
Full-year earnings
Add to Google Calendar
2024
Nov 7
Earnings Time TBD
Q3 earnings
Add to Google Calendar
Nov 12
Est.
Earnings 16:10 approx.
Q3 earnings (predicted)
Add to Google Calendar
2027
Jan 14
Est.
Earnings 16:10 approx.
FY earnings (predicted)
Add to Google Calendar
Mar 16
Est.
Filing Time TBD
Annual report (10-K) filing due (est.)
Add to Google Calendar

KPI highlights

FY25
Revenue $37M YoY +4.1%
Operating income $-15M margin -39.8%
Net income $-8M YoY
EPS $-0.13 YoY
P/E
ROE -138.9% Equity ratio 13% Typical equity ratios vary a lot by industry. Banks, brokerages, and other financial companies tend to run lower ratios because leverage (using other people's capital) is core to their business model — a low ratio there isn't a sign of financial weakness.

Quarterly fundamentals

Income & cash flow Unit: $1M
Quarter FY24 Q4FY25 Q1FY25 Q2FY25 Q3FY25 Q4FY26 Q1
Revenue 9.158.739.629.499.238.86
Operating income -4.05-3.89-3.62-2.86-3.88-3.04
Net income -7.88-1.481.95-3.17-5.50-5.13
Operating CF 2.76-2.11-5.41-2.88

Company news

Ownership over time

Share of total shares outstanding (disclosed major holdings + undisclosed)(2014–2026)

機関投資家 6.6%未開示 93.4%2014201620182020202220242026
機関投資家 6.6%未開示 93.4%14Q315Q316Q317Q318Q319Q320Q321Q322Q323Q324Q325Q426Q1
機関投資家未開示・浮動株

「国内機関」は信託銀行の名義口座(年金・パッシブ・一部海外資本を含む)を集計し、実質保有者へは分解していません。分類は開示名称からの推定です。

Top shareholders — rank & share

AVENIR CORP 2.1%AVENIR CORPVANGUARD CAPITAL M 0.7%VANGUARD CAPITAL MANAGEMENT LLCSkylands Capital, 0.7%Skylands Capital, LLCNEUBERGER BERMAN G 0.7%NEUBERGER BERMAN GROUP LLCCM Management, LLC 0.6%CM Management, LLCBlackRock, Inc. 0.3%BlackRock, Inc.GEODE CAPITAL MANA 0.3%GEODE CAPITAL MANAGEMENT, LLCSargent Investment 0.2%Sargent Investment Group, LLCPathstone Holdings 0.2%Pathstone Holdings, LLC2014201620182020202220242026
AVENIR CORP 2.1%AVENIR CORPVANGUARD CAPITAL M 0.7%VANGUARD CAPITAL MANAGEMENT LLCSkylands Capital, 0.7%Skylands Capital, LLCNEUBERGER BERMAN G 0.7%NEUBERGER BERMAN GROUP LLCCM Management, LLC 0.6%CM Management, LLCBlackRock, Inc. 0.3%BlackRock, Inc.GEODE CAPITAL MANA 0.3%GEODE CAPITAL MANAGEMENT, LLCSargent Investment 0.2%Sargent Investment Group, LLCPathstone Holdings 0.2%Pathstone Holdings, LLC14Q315Q316Q317Q318Q319Q320Q321Q322Q323Q324Q325Q426Q1

Top shareholders — actual figures (as of 2026)

Holder Shares held Ratio Source
AVENIR CORP 5,215,776 2.1% 13F
VANGUARD CAPITAL MANAGEMENT LLC 1,879,989 0.7% 13F
Skylands Capital, LLC 1,707,498 0.7% 13F
NEUBERGER BERMAN GROUP LLC 1,683,007 0.7% 13F
CM Management, LLC 1,476,500 0.6% 13F
BlackRock, Inc. 782,992 0.3% 13F
GEODE CAPITAL MANAGEMENT, LLC 707,262 0.3% 13F
Sargent Investment Group, LLC 549,900 0.2% 13F
Pathstone Holdings, LLC 499,955 0.2% 13F
VANGUARD FIDUCIARY TRUST CO 313,856 0.1% 13F
その他機関投資家(13F 24社) 270,613 0.1% 13F
CIBC Bancorp USA Inc. 172,649 0.1% 13F
STATE STREET CORP 159,293 0.1% 13F
OSAIC HOLDINGS, INC. 130,419 0.1% 13F
UBS Group AG 115,200 0.0% 13F
RAYMOND JAMES FINANCIAL INC 107,751 0.0% 13F
NWF Advisory Services Inc. 104,139 0.0% 13F
RENAISSANCE TECHNOLOGIES LLC 100,720 0.0% 13F
MORGAN STANLEY 100,169 0.0% 13F
NORTHERN TRUST CORP 92,540 0.0% 13F
Key Client Fiduciary Advisors, LLC 78,457 0.0% 13F
Waverly Advisors, LLC 55,556 0.0% 13F
STIFEL FINANCIAL CORP 48,000 0.0% 13F
GOLDMAN SACHS GROUP INC 43,947 0.0% 13F
BANK OF AMERICA CORP /DE/ 39,123 0.0% 13F
XTX Topco Ltd 35,570 0.0% 13F

Source:SEC EDGAR(DEF 14A・13D/G・13F) Classification inferred from disclosed names

F-Score (Piotroski)

3/9

Checks financial health against 9 criteria and shows how many are met as a fraction (more ✓ marks is healthier). Items with no data are shown as “—” — they're simply excluded from judgment, not counted against the score.

Positive ROA ROA -18.6%
Positive operating cash flow $-12M
ROA improved YoY -43.7% → -18.6%
Operating CF exceeds net income (accrual quality) OCF $-12M / net income $-8M
Equity ratio improved* Substitute for the original “decrease in long-term debt” 23.4% → 13.4%
Current ratio improved 2.20× → 2.13×
No dilution (shares outstanding did not increase) 54,830,146 → 62,804,305
Gross margin improved 69.9% → 71.5%
Asset turnover improved 0.75× → 0.84×

This score is reference information based on our own financial metrics. It is NOT a credit rating issued by a credit rating agency under Article 66-27 of the Financial Instruments and Exchange Act, and is NOT investment advice or a recommendation. Make investment decisions at your own responsibility.

Fact checklist

FY25
Equity ratio 13.4%
Current ratio 2.1×
Years of positive operating CF 0 of last 12 yrs
Payout ratio 0%
Latest fiscal year result Loss (net loss $8M)

Performance history

Last 10 years
$0M$10M$20M$30M$40M FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25

Income & assets

Unit: $1M
Item FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Revenue 9.5315.222.539.540.129.431.135.637.1
Operating income -11.5-9.84-15.6-19.0-10.4-22.7-31.5-31.9-16.5-14.7
Ordinary income
Net income -11.8-8.46-17.2-19.3-7.84-24.6-32.8-29.2-20.7-8.20
Total assets 9.6924.134.227.490.089.563.253.047.444.2
Equity 1.3410.316.93.4279.262.635.423.511.15.90

A “—” means data wasn't available for that period — it's not a display error or an unusual value.

Indicators & cash flow

Unit: $1M
Item FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
EPS $-0.60$-0.20$-0.57$-0.75$-0.64$-0.38$-0.13
ROE -879.5%-82.4%-101.6%-563.6%-9.9%-39.2%-92.8%-124.6%-186.5%-138.9%
Operating CF -6.73-6.46-10.8-16.8-5.61-14.0-28.2-21.7-14.4-12.4
Investing CF 1.60-1.68-1.52-1.52-1.68-4.28-6.46-0.94-0.67-0.42
Financing CF 5.0620.117.58.1866.30.724.9614.59.339.31
FCF -7.29-18.3-34.7-22.6-15.1-12.9

A “—” means data wasn't available for that period — it's not a display error or an unusual value.

Source: SEC EDGAR (10-K, etc.) (fetched 2026-07-12) *Some metrics supplemented from additional sources

Key financial metrics

3-year revenue growth

Sector positioning

Relative standing within the sector

Data provided by Twelve Data